We are live on ! Find out more
DMAQR

Deep Medicine Acquisition Corp. Rights
DMAQR

Delisted

DMAQR was delisted on the 31st of January, 2024.

Back to rankings

33 hedge funds and large institutions have $3.2M invested in Deep Medicine Acquisition Corp. Rights in 2021 Q4 according to their latest regulatory filings, with 33 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
33
Holders Change
+33
Holders Change %
–
% of All Funds
0.51%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
33
Increased
–
Reduced
–
Closed
–
Calls
$336K
Puts
–
Net Calls
+$336K
Net Calls Change
+$336K

Top Buyers

Rank Fund Capital Flow
1
MP
Mangrove Partners
Connecticut
+$474K
2
CAC
Cowen and Company
New York
+$342K
3
OCAM
Owl Creek Asset Management
New York
+$237K
4
YCM
Yakira Capital Management
Connecticut
+$237K
5
Hudson Bay Capital Management
Hudson Bay Capital Management
Connecticut
+$206K

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
MP
1
Mangrove Partners
Connecticut
$480K +$474K +1,500,000 New
CAC
2
Cowen and Company
New York
$346K +$342K +1,081,251 New
OCAM
3
Owl Creek Asset Management
New York
$240K +$237K +750,000 New
YCM
4
Yakira Capital Management
Connecticut
$240K +$237K +750,000 New
Hudson Bay Capital Management
5
Hudson Bay Capital Management
Connecticut
$208K +$206K +650,000 New
SCM
6
Shaolin Capital Management
Florida
$162K +$160K +506,323 New
D.E. Shaw & Co
7
D.E. Shaw & Co
New York
$154K +$152K +480,000 New
KPF
8
K2 Principal Fund
Ontario, Canada
$152K +$150K +475,000 New
OCM
9
Oaktree Capital Management
California
$136K +$134K +425,000 New
AA
10
AQR Arbitrage
Connecticut
$120K +$119K +375,000 New
WAM
11
Wolverine Asset Management
Illinois
$111K +$110K +348,800 New
HIM
12
HGC Investment Management
Ontario, Canada
$96K +$94.9K +300,000 New
MF
13
Magnetar Financial
Illinois
$96K +$94.9K +300,000 New
WA
14
Whitebox Advisors
Minnesota
$80K +$79.1K +250,000 New
SCM
15
Saba Capital Management
New York
$80K +$79.1K +250,076 New
PC
16
Periscope Capital
Ontario, Canada
$78K +$76.5K +241,900 New
CH
17
CVI Holdings
Delaware
$74K +$73K +230,731 New
CCM
18
Context Capital Management
California
$63K +$62.6K +198,000 New
MTCM
19
Mint Tower Capital Management
Netherlands
$62K +$61.4K +194,190 New
RCM
20
Rivernorth Capital Management
Florida
$48K +$47.4K +150,000 New
Walleye Capital
21
Walleye Capital
New York
$45K +$44.5K +140,800 New
SIA
22
SkyView Investment Advisors
New Jersey
$32K +$31.6K +100,000 New
Walleye Trading
23
Walleye Trading
New York
$25K +$25.1K +79,200 New
TCM
24
Tuttle Capital Management
Connecticut
$22K +$21.8K +69,024 New
HF
25
HRT Financial
New York
$15K +$15.7K +49,615 New
1
2

DMAQR Hedge Fund Activity: Q4 2021 in Review

33 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in Deep Medicine Acquisition Corp. Rights (DMAQR) for Q4 2021, worth a combined $3.2M.

Buyers outnumbered sellers: 33 funds opened new DMAQR positions and 0 closed out — a net gain of 33 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Mangrove Partners, opening a new position worth an estimated $474K.

  • 33 institutional investors held Deep Medicine Acquisition Corp. Rights (DMAQR) as of Q4 2021, up from 0 in Q3 2021.
  • Funds reported $3.2M of Deep Medicine Acquisition Corp. Rights stock for Q4 2021.
  • 33 funds opened new Deep Medicine Acquisition Corp. Rights positions in Q4 2021 and 0 closed out, a net change of +33 holders.
  • The largest Deep Medicine Acquisition Corp. Rights buyer in Q4 2021 was Mangrove Partners, an estimated $474K added.

Based on aggregated 13F filings for Q4 2021.